Analysts have been eager to weigh in on the Healthcare sector with new ratings on Voyager Therapeutics (VYGR – Research Report), Staar Surgical (STAA – Research Report) and Hyperfine (HYPR – Research Report).

Voyager Therapeutics (VYGR)

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Voyager Therapeutics, with a price target of $12.00. The company’s shares closed last Tuesday at $4.21, close to its 52-week low of $4.13.

According to TipRanks.com, Zhu has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -3.8% and a 25.4% success rate. Zhu covers the Healthcare sector, focusing on stocks such as Adaptimmune Therapeutics, Iovance Biotherapeutics, and Crispr Therapeutics AG.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Voyager Therapeutics with a $15.83 average price target, representing a 206.8% upside. In a report issued on January 27, H.C. Wainwright also reiterated a Buy rating on the stock with a $30.00 price target.

Staar Surgical (STAA)

BTIG analyst Ryan Zimmerman downgraded Staar Surgical to Hold today. The company’s shares closed last Tuesday at $21.88, close to its 52-week low of $21.13.

According to TipRanks.com, Zimmerman is a 2-star analyst with an average return of 0.3% and a 46.3% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Treace Medical Concepts, and Zimmer Biomet Holdings.

The word on The Street in general, suggests a Hold analyst consensus rating for Staar Surgical with a $26.50 average price target, a 18.3% upside from current levels. In a report released today, William Blair also downgraded the stock to Hold.

Hyperfine (HYPR)

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Hyperfine, with a price target of $1.10. The company’s shares closed last Tuesday at $1.12.

According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of 13.6% and a 64.5% success rate. Biegelsen covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Bausch + Lomb Corporation, and Inspire Medical Systems.

The word on The Street in general, suggests a Hold analyst consensus rating for Hyperfine with a $1.10 average price target.